| Rabia Akbar, MD | |
|
2363 W Jefferson Ave Ste 100, Trenton, MI 48183-2705 | |
| (734) 676-2800 | |
| (734) 676-4418 |
| Full Name | Rabia Akbar |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2363 W Jefferson Ave Ste 100, Trenton, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114149283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 125-052124 (Illinois) | Secondary |
| 208000000X | Pediatrics | 4301500768 (Michigan) | Secondary |
| 208000000X | Pediatrics | 35096044 (Ohio) | Primary |
| Entity Name | Mercy Health Physicians-north Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609000769 PECOS PAC ID: 2668522400 Enrollment ID: O20090616000750 |
News Archive
A new study using organ-on-a-chip technology reveals how overactive immune cells aggravate heart valve disease and how this damaging hyperactivity could potentially be controlled.
Self-collected saliva and deep nasal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2, the virus that causes COVID-19, according to a new study conducted by ARUP Laboratories and University of Utah Health.
Progenics Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), along with the European Medicines Agency (EMA) of the European Union (E.U.) and Health Canada, the Canadian Regulatory Agency, have each approved single-use, pre-filled syringes of RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection for use in their respective territories. These pre-filled syringes provide a simplified dosing option for the treatment of opioid-induced constipation (OIC) in palliative-care patients with advanced illness.
A new study by US-based researchers – at the Northwest Mental Illness Research, Education and Clinical Center and Columbia University – has found that healthcare workers have experienced significant psychiatric distress during the pandemic.
› Verified 1 days ago
| Entity Name | Incare Health Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235422403 PECOS PAC ID: 5092980730 Enrollment ID: O20111208000530 |
News Archive
A new study using organ-on-a-chip technology reveals how overactive immune cells aggravate heart valve disease and how this damaging hyperactivity could potentially be controlled.
Self-collected saliva and deep nasal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2, the virus that causes COVID-19, according to a new study conducted by ARUP Laboratories and University of Utah Health.
Progenics Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), along with the European Medicines Agency (EMA) of the European Union (E.U.) and Health Canada, the Canadian Regulatory Agency, have each approved single-use, pre-filled syringes of RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection for use in their respective territories. These pre-filled syringes provide a simplified dosing option for the treatment of opioid-induced constipation (OIC) in palliative-care patients with advanced illness.
A new study by US-based researchers – at the Northwest Mental Illness Research, Education and Clinical Center and Columbia University – has found that healthcare workers have experienced significant psychiatric distress during the pandemic.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rabia Akbar, MD 2200 Jefferson Ave Fl 5, Toledo, OH 43604-7103 Ph: () - | Rabia Akbar, MD 2363 W Jefferson Ave Ste 100, Trenton, MI 48183-2705 Ph: (734) 676-2800 |
News Archive
A new study using organ-on-a-chip technology reveals how overactive immune cells aggravate heart valve disease and how this damaging hyperactivity could potentially be controlled.
Self-collected saliva and deep nasal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2, the virus that causes COVID-19, according to a new study conducted by ARUP Laboratories and University of Utah Health.
Progenics Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), along with the European Medicines Agency (EMA) of the European Union (E.U.) and Health Canada, the Canadian Regulatory Agency, have each approved single-use, pre-filled syringes of RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection for use in their respective territories. These pre-filled syringes provide a simplified dosing option for the treatment of opioid-induced constipation (OIC) in palliative-care patients with advanced illness.
A new study by US-based researchers – at the Northwest Mental Illness Research, Education and Clinical Center and Columbia University – has found that healthcare workers have experienced significant psychiatric distress during the pandemic.
› Verified 1 days ago
Meenakshi Soi, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2421 Fort Street, Trenton, MI 48183 Phone: 734-676-0800 | |
Susan B Chamberlain, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2363 W Jefferson Ave, Trenton, MI 48183 Phone: 734-676-2800 Fax: 734-676-4418 | |
Heather G Cadena, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2363 W Jefferson Ave, Trenton, MI 48183 Phone: 734-676-2800 Fax: 734-676-4418 |